Is ACLHF or JNJ a better dividend investment in 2026?

ACLHF currently yields 4938.27% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: ACLHF offers higher current income.

What is the dividend yield difference between ACLHF and JNJ?

ACLHF has a forward dividend yield of 4938.27% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 4936.14 percentage points.

Home › Compare › ACLHF vs JNJ

ACLHF vs JNJ: Dividend Comparison 2026

ACLHF yields 4938.27% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ACLHF wins by $55146348937607.21M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ACLHF

● Live price

4938.27%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$55146348937607.24M

Annual income

$53,033,758,961,414,200,000.00

Full ACLHF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — ACLHF vs JNJ

📍 ACLHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ACLHF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ACLHF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ACLHF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACLHF

Annual income on $10K today (after 15% tax)

$419,753.09/yr

After 10yr DRIP, annual income (after tax)

$45,078,695,117,202,070,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, ACLHF beats the other by $45,078,695,117,202,070,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACLHF + JNJ for your $10,000?

ACLHF: 50%JNJ: 50%

100% JNJ50/50100% ACLHF

Portfolio after 10yr

$27573174468803.64M

Annual income

$26,516,879,480,707,105,000.00/yr

Blended yield

96.17%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ACLHF

No analyst data

Altman Z

1.7

Piotroski

3/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACLHF buys

JNJ buys

No recent congressional trades found for ACLHF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricACLHFJNJ

Forward yield	4938.27% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$55146348937607.24M ✓	$30.3K
Annual income after 10y	$53,033,758,961,414,200,000.00 ✓	$4,689.40
Total dividends collected	$55003355952995.54M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ACLHF vs JNJ ($10,000, DRIP)

Year	ACLHF Portfolio	ACLHF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$504,527	$493,827.16	$10,592	$272.30	+$493.9K → ACLHF
2	$23,824,817	$23,284,973.37	$11,289	$357.73	+$23.81M → ACLHF
3	$1,053,123,085	$1,027,630,530.32	$12,123	$472.89	+$1053.11M → ACLHF
4	$43,579,292,978	$42,452,451,277.21	$13,141	$629.86	+$43579.28M → ACLHF
5	$1,688,429,051,261	$1,641,799,207,774.13	$14,408	$846.81	+$1688429.04M → ACLHF
6	$61,254,845,187,941	$59,448,226,103,092.12	$16,021	$1,151.60	+$61254845.17M → ACLHF
7	$2,081,181,684,947,090	$2,015,639,000,595,993.00	$18,122	$1,588.22	+$2081181684.93M → ACLHF
8	$66,229,598,087,621,200	$64,002,733,684,727,816.00	$20,930	$2,228.20	+$66229598087.60M → ACLHF
9	$1,974,383,155,320,608,300	$1,903,517,485,366,853,600.00	$24,792	$3,191.91	+$1974383155320.58M → ACLHF
10	$55,146,348,937,607,240,000	$53,033,758,961,414,200,000.00	$30,274	$4,689.40	+$55146348937607.21M → ACLHF

ACLHF vs JNJ: Complete Analysis 2026

ACLHF — Stock

ACME Lithium Inc., a mineral exploration company, engages in acquiring, exploring, and evaluating lithium properties in the United States. It holds a 100% interest under an option agreement in 64 mining claims totaling 1,280 acres; and owns 100% interest in 58 claims totaling 1,160 acres in Clayton Valley in Esmeralda County, Nevada. The company also owns a 100% interest in 81 lode mining claims totaling 1,620 acres in Fish Lake Valley, located in Esmeralda County, Nevada. In addition, it has an option to acquire the Cat-Euclid Lake Project that consists of 6 claims totaling approximately 2,930 acres; and the Shatford Lake Project comprising 21 claims totaling approximately 8,883 acres located in southeastern Manitoba, Canada. The company was incorporated in 2017 and is based in Vancouver, Canada.

Full ACLHF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this ACLHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACLHF vs SCHD ACLHF vs JEPI ACLHF vs O ACLHF vs KO ACLHF vs MAIN ACLHF vs ABBV ACLHF vs MRK ACLHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.